Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maya Glover

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Translational Cancer Research|June 17, 2024
The role of CD4<sup>+</sup> CAR T cells in cancer immunotherapyCamilla Bove, John Maher, Maya Glover
Biologics : Targets & Therapy|May 27, 2021
How Can We Engineer CAR T Cells to Overcome Resistance?Maya Glover, Stephanie Avraamides, John Maher
Human Vaccines & Immunotherapeutics|February 8, 2026
Harnessing the NKG2D immune surveillance pathway using engineered T-cells for the treatment of human diseaseMaya Glover, John Maher, David Marc Davies
Expert Review of Clinical Immunology|July 18, 2024
CAR-T cell technologies that interact with the tumour microenvironment in solid tumoursChelsea Alice Taylor, Maya Glover, John Maher
Plos Pathogens|November 16, 2019
Trickle infection and immunity to Trichuris murisMaya Glover, Stefano A P Colombo, David J Thornton, et al.
Infection and Immunity|July 29, 2020
Importance of the Immunodominant CD8<sup>+</sup> T Cell Epitope of Plasmodium berghei Circumsporozoite Protein in Parasite- and Vaccine-Induced ProtectionMatthew P Gibbins, Katja Müller, Maya Glover, et al.
Cell Reports. Medicine|November 20, 2024
Solid tumor immunotherapy using NKG2D-based adaptor CAR T cellsJana Obajdin, Daniel Larcombe-Young, Maya Glover, et al.
Cell Reports. Medicine|January 14, 2022
Synergistic T cell signaling by 41BB and CD28 is optimally achieved by membrane proximal positioning within parallel chimeric antigen receptorsTamara Muliaditan, Leena Halim, Lynsey M Whilding, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Translational Cancer Research|June 17, 2024
The role of CD4<sup>+</sup> CAR T cells in cancer immunotherapyCamilla Bove, John Maher, Maya Glover
Biologics : Targets & Therapy|May 27, 2021
How Can We Engineer CAR T Cells to Overcome Resistance?Maya Glover, Stephanie Avraamides, John Maher
Human Vaccines & Immunotherapeutics|February 8, 2026
Harnessing the NKG2D immune surveillance pathway using engineered T-cells for the treatment of human diseaseMaya Glover, John Maher, David Marc Davies
Expert Review of Clinical Immunology|July 18, 2024
CAR-T cell technologies that interact with the tumour microenvironment in solid tumoursChelsea Alice Taylor, Maya Glover, John Maher
Plos Pathogens|November 16, 2019
Trickle infection and immunity to Trichuris murisMaya Glover, Stefano A P Colombo, David J Thornton, et al.
Infection and Immunity|July 29, 2020
Importance of the Immunodominant CD8<sup>+</sup> T Cell Epitope of Plasmodium berghei Circumsporozoite Protein in Parasite- and Vaccine-Induced ProtectionMatthew P Gibbins, Katja Müller, Maya Glover, et al.
Cell Reports. Medicine|November 20, 2024
Solid tumor immunotherapy using NKG2D-based adaptor CAR T cellsJana Obajdin, Daniel Larcombe-Young, Maya Glover, et al.
Cell Reports. Medicine|January 14, 2022
Synergistic T cell signaling by 41BB and CD28 is optimally achieved by membrane proximal positioning within parallel chimeric antigen receptorsTamara Muliaditan, Leena Halim, Lynsey M Whilding, et al.
Pageof 1